BioPlus® Specialty Pharmacy Services, Inc. Prepares to Unveil Results of Therapy Management Program
Altamonte Springs, Fla., July 12
BioPlus Specialty Pharmacy announced today that it is prepared to release results of its ongoing Therapy Management programs.
These programs, customized to Specialty therapy regimens, are used to monitor patient treatments and therapeutic outcomes.
“As the pioneers of Specialty Pharmacy, BioPlus has had one goal: to measurably improve both financial and therapeutic
outcomes of biotech infusions and injectables. For years, health plans have been trying to get a handle on their specialty
drug spending. This has led to everyone searching for better AWP minus pricing. What that created was a bidding war which
has led to poorer compliance and higher drug spending.” said Steve Vogt, Pharm D and President of BioPlus.
Enoch Strollo, V.P. of Sales and Marketing added, “Managed care is losing $100 Billion dollars a year on non-compliance,
while drug manufacturers are losing $30 Billion dollars a year. Patients that do not complete their treatment regimens equal
wasted claims, it doesn’t matter what you are paying it’s a total loss.”
Dr. Vogt continued, “Our Therapy Management programs are showing significant completion of therapy results and nearly double
the national averages in compliance. We are also seeing trends in drug effectiveness and common drug reactions. The data that we
collect can help Managed Care make effective formulary decisions, see results and better track their members who are on specialty
medications. Additionally, this data is real life post-market clinical trial information that can help manufacturers.”
For more information or results from BioPlus’ Therapy Management data, please contact Enoch Strollo at 888-292-0744
BioPlus Specialty Pharmacy Services Inc. Provides:
- Individual pharmaceutical care plans.
- Highly trained team of experienced professionals.
- Focus on the total cost of the therapy not just the unit cost of the pharmaceutical.
- Timely utilization reports to manufacturers, payer and MCO.
- Specialty pharmacy benefit consultants.
- Higher compliance and completion of therapy.